ArticleAmerican journal of cancer research2025
Vulvar dermatofibrosarcoma protuberans: a case series.
Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vulvar dermatofibrosarcoma protuberans in a 55-year-old female: A case report, surgical reconstruction approach and literature review.Gynecologic oncology reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatofibrosarcoma protuberans (DFSP) is a rare, superficial low - to intermediate-grade sarcoma that typically presents as an asymptomatic slow-growing indurated dermal plaque. Although DFSP has a relatively high local recurrence rate, distant metastasis is rare. DFSP primarily occurs on the trunk and extremities but is seldom reported in the vulva. Due to its rarity, the clinical characteristics, pathological diagnosis, prognosis, and optimal management of vulvar DFSP remain poorly characterized. We retrospectively analyzed vulvar DFSP cases from our institution (January 2010 - January 2023). Clinical data and follow-up were obtained from hospital records, and imaging studies were reviewed via the picture archiving and communication system. Seven patients were included, with a median symptom-onset age of 44.3 years (range, 27-73). Patients typically presented with firm, asymptomatic masses. The labia majora was most commonly affected (n = 6, 85.7%). Tumor size averaged 4.3 cm (range, 2.0-6.5). All patients underwent excisional biopsy followed by wide local excision; none received lymphadenectomy. Surgical margins were documented in six patients, with negative margins achieved in five after initial wide excision. Over a mean follow-up of 27.3 months (range, 12-54), one patient (14.3%) experienced local recurrence. No recurrence occurred in patients with negative margins. Vulvar DFSP predominantly affects young and middle-aged women, manifesting as vulvar masses of variable size. Wide local excision is the primary treatment. While vulvar DFSP has a propensity for local recurrence, widely negative margins appear protective. Long-term follow-up is recommended to monitor for recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.